Case Control Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Jan 26, 2019; 7(2): 130-136
Published online Jan 26, 2019. doi: 10.12998/wjcc.v7.i2.130
Table 1 Patient characteristics
VariablenFrequency [n (%), or mean ± SD]Median (range)
Age930.00 ± 15.7529.00 (12.00-60.00)
Gender (male/female)94 (44.4)/5 (55.6)
Hepatitis B virus90 (0)
Hepatitis C virus90 (0)
Alcohol abuse90 (0)
Vascular obstruction
IVC obstruction92 (22.2)
RHV obstruction98 (88.9)
MHV obstruction97 (77.8)
LHV obstruction99 (100.0)
All HVs obstruction96 (66.7)
Portal vein thrombosis90 (0)
Clinical presentations and signs
Hepatic encephalopathy before TIPS90 (0)
Gastrointestinal bleeding93 (33.3)
Abdominal pain92 (22.2)
Abdominal distension97 (77.8)
Abdominal varices91 (11.1)
Limb swelling91 (11.1)
Pigmentation91 (11.1)
Limb ulcer91 (11.1)
CT signs
Hydrothorax on CT93 (33.3)
Ascites on CT94 (44.4)
Splenomegaly on CT98 (88.9)
Hepatic patchy enhancement on CT97 (77.8)
Gastroesophageal varices on CT97 (77.8)
Paraesophageal varices on CT91 (11.1)
Laboratory tests
Hemoglobin (g/L)9122.67 ± 34.81127.00 (82.00-171.00)
White blood cell (109/L)96.86 ± 2.856.67 (2.99-12.48)
Platelet count (109/L)9122.22 ± 69.32109.00 (42.00-270.00)
Alanine aminotransferase (U/L)929.22 ± 17.5623.00 (13.00-71.00)
Aspartate aminotransferase (U/L)947.22 ± 20.9739.00 (18.00-71.00)
Alkaline phosphatase (U/L)9178.33 ± 69.20148.00 (96.00-288.00)
Gamma glutamyl transferase (U/L)993.44 ± 42.2184.00 (19.00-161.00)
Total bilirubin (mmol/L)986.98 ± 91.8142.80 (18.90-262.40)
Direct bilirubin (mmol/L)957.71 ± 68.4217.30 (6.20-180.00)
Albumin (g/L)936.19 ± 7.0839.60 (22.20-44.10)
Prothrombin time (s)955.67 ± 15.3356.00 (25.00-78.00)
International normalized ratio91.48 ± 0.431.37 (1.12-2.55)
Serum creatinine (mmol/L)951.00 ± 14.6550.00 (29.00-76.00)
Blood urea nitrogen (mmol/L)95.06 ± 1.515.15 (2.94-8.27)
Sodium (mmol/L)9134.78 ± 8.56138.00 (120.00-143.00)
Potassium (mmol/L)94.33 ± 0.644.17 (3.77-5.77)
Collagen proportionate area923.44 ± 13.8823.07 (0-40.20)
Shunt dysfunction after TIPS92 (22.2)
Hepatic encephalopathy after TIPS91 (11.1)
Table 2 Correlation analysis of collagen proportionate area
VariablenPearson coefficientP value
Age90.3600.342
Gender (male/female)90.0380.922
Hepatitis B virus9NANA
Hepatitis C virus9NANA
Alcohol abuse9NANA
Vascular obstruction
IVC obstruction9-0.3900.300
RHV obstruction9-0.5020.168
MHV obstruction9-0.1360.726
LHV obstruction9NANA
All HVs obstruction9-0.4550.218
Portal vein thrombosis9NANA
Clinical presentations and signs
Hepatic encephalopathy before TIPS9NANA
Gastrointestinal bleeding90.8320.005
Abdominal pain9-0.2570.504
Abdominal distension9-0.0930.813
Abdominal varices9-0.3420.367
Limb swelling9-0.2330.547
Pigmentation9-0.3420.367
Limb ulcer9NANA
CT signs
Hydrothorax on CT90.1420.716
Ascites on CT9-0.0120.975
Splenomegaly on CT9-0.5020.168
Hepatic patchy enhancement on CT9-0.0370.924
Gastroesophageal varices on CT90.2190.572
Paraesophageal varices on CT90.6330.067
Laboratory tests
Hemoglobin (g/L)90.1570.687
White blood cell (109/L)9-.0250.949
Platelet count (109/L)90.2420.530
Alanine aminotransferase (U/L)9-0.6940.038
Aspartate aminotransferase (U/L)9-0.6420.062
Alkaline phosphatase (U/L)9-0.3580.344
Gamma glutamyl transferase (U/L)90.0800.837
Total bilirubin (μmol/L)9-0.3380.373
Direct bilirubin (μmol/L)9-0.4150.267
Albumin (g/L)90.3480.358
Prothrombin time (seconds)90.680.044
International normalized ratio9-0.6380.065
Serum creatinine (μmol/L)90.0190.962
Blood urea nitrogen (mmol/L)9-0.4110.272
Sodium (mmol/L)90.2720.478
Potassium (mmol/L)9-0.3760.319
Shunt dysfunction after TIPS9-0.1680.665
Hepatic encephalopathy after TIPS9-0.4530.221